Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Nektar Therapeutics”

423 pharma patents match "Nektar Therapeutics" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 423
Index total 30,257
Page 7 / 18

Quick answer

This filtered view shows 423 pharmaceutical patents matching "Nektar Therapeutics" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

423 results for “Nektar Therapeutics” · 30,257 patents in full index Clear search

  1. US 9226969

    Salt form of a multi-arm polymer-drug conjugate

    Nektar Therapeutics · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  2. US 9226970

    Oligomer modified diaromatic substituted compounds

    Nektar Therapeutics · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  3. US 9226971

    N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides

    Nektar Therapeutics · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  4. US 9228053

    Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

    Nektar Therapeutics · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  5. US 9199954

    Non-ring hydroxy substituted taxanes and methods for synthesizing the same

    Nektar Therapeutics · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  6. US 9192681

    Oligomer-amino acid conjugates

    Nektar Therapeutics · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  7. US 9187569

    Branched polymers

    Nektar Therapeutics · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted
  8. US 9173951

    Carbohydrate-based drug delivery polymers and conjugates thereof

    Nektar Therapeutics · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted
  9. US 9173947

    Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom

    Nektar Therapeutics · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted
  10. US 9169350

    N-maleimidyl polymer derivatives

    Nektar Therapeutics · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted
  11. US 9168311

    Oligomer-dantrolene conjugates and related compounds

    Nektar Therapeutics · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted
  12. US 9155797

    Oligomer-cannabinoid conjugates

    Nektar Therapeutics · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  13. US 9149538

    Oligomer conjugates of heteropentacyclic nucleosides

    Nektar Therapeutics · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  14. US 9149539

    Crystalline naloxol-PEG conjugate

    Nektar Therapeutics · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  15. US 9132200

    Oligomer-calcium channel blocker conjugates

    Nektar Therapeutics · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted
  16. US 9126926

    Oligomer-anticholinergic agent conjugates

    Nektar Therapeutics · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  17. US 9120031

    Compositions of particulate coformulation

    Nektar Therapeutics · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  18. US 9107956

    Oligomer-protease inhibitor conjugates

    Nektar Therapeutics · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  19. US 9101670

    Conjugates of an anti-TNF-α antibody

    Nektar Therapeutics · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted
  20. US 9095620

    Reagents

    Nektar Therapeutics · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted
  21. US 9095622

    Oligomer-protein tyrosine kinase inhibitor conjugates

    Nektar Therapeutics · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted
  22. US 9095621

    Oligome-bis-chromonyl compound conjugates

    Nektar Therapeutics · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted
  23. US 9096517

    Oligomer-containing pyrrolidine compounds

    Nektar Therapeutics · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted
  24. US 9090740

    Methods for preparing polymeric reagents

    Nektar Therapeutics · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted